Editas Medicine Inc. (EDIT)
NASDAQ · Healthcare
Editas Medicine Inc. Operating Income 2016–2025
Editas Medicine Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Editas Medicine Inc. operating income for the quarter ending March 31, 2026 was -25.0 M, a 67.17% decrease year-over-year.
- Editas Medicine Inc. operating income for the twelve months ending March 31, 2026 was -177.3 M, a 30.41% decrease year-over-year.
- Editas Medicine Inc. annual operating income for 2025 was -160.0 M, a 36.29% decrease from 2024.
- Editas Medicine Inc. annual operating income for 2024 was -251.2 M, a 48.45% increase from 2023.
- Editas Medicine Inc. annual operating income for 2023 was -169.2 M, a 25.12% decrease from 2022.
- Editas Medicine Inc. annual operating income for 2022 was -225.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Editas Medicine Inc. Operating Income — FAQ
Editas Medicine Inc. (EDIT) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Editas Medicine Inc.'s operating income?
Editas Medicine Inc. (EDIT) reported operating income of -$160M for fiscal 2025.
Where can I see EDIT's operating income history?
The chart and table above show Editas Medicine Inc.'s operating income by year and by quarter, including the growth rate.